Indefinite-Lived Research and Development Assets
Altria Group Indefinite-Lived Research and Development Assets remained flat by 0.0% to $11.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $11.09B to $11.09B. Over 3 years (FY 2022 to FY 2025), Indefinite-Lived Research and Development Assets shows relatively stable performance with a -1.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
Detailed definition
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Peer comparison
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
indefinite_lived_rd_assetsHistorical Data
| Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.44B | $11.44B | $11.44B | $11.44B | $11.09B | $11.09B | $11.09B | $11.09B | $11.09B | $11.09B | $11.09B | $11.09B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -3.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +0.0% | -3.1% | -3.1% | -3.1% | — | +0.0% | +0.0% | +0.0% | +0.0% |
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is Altria Group's indefinite-lived research and development assets?
- Altria Group (MO) reported indefinite-lived research and development assets of $11.09B in Q1 2026.
- How has Altria Group's indefinite-lived research and development assets changed year-over-year?
- Altria Group's indefinite-lived research and development assets decreased by 0.0% year-over-year, from $11.09B to $11.09B.
- What is the long-term trend for Altria Group's indefinite-lived research and development assets?
- Over 3 years (2022 to 2025), Altria Group's indefinite-lived research and development assets has grown at a -1.0% compound annual growth rate (CAGR), from $11.44B to $11.09B.
- What does indefinite-lived research and development assets mean?
- The value of ongoing research projects acquired from other companies that are not yet ready for sale.